Treatment decisions in oncology are commonly informed by the visual assessment of immunohistochemistry biomarkers by pathologists. However, pathology services face mounting pressure as diagnostic...
The new challenge is the usage of in silico methods in the field of
nanotechnology. Nanotechnology is an innovative science that involves
the designing, characterization, production...
There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real...